Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cor van den Bos

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Blood Neoplasia|June 2, 2025
Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in BelgiumPaul G Kemps, F J Sherida H Woei-A-Jin, Patrick Schöffski, et al.
Frontiers in Immunology|January 31, 2020
Apparent Lack of <i>BRAF</i><sup></sup> Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8<sup>+</sup> T Cells in Langerhans Cell HistiocytosisPaul G Kemps, Timo C Zondag, Eline C Steenwijk, et al.
Blood|September 24, 2024
Recurrent CLTC::SYK fusions and CSF1R mutations in juvenile xanthogranuloma of soft tissuePaul G Kemps, Hans J Baelde, Ruben H P Vorderman, et al.
Blood Advances|September 9, 2022
Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort studyPaul G Kemps, Timo C E Zondag, Helga B Arnardóttir, et al.
Hemasphere|June 9, 2026
Efficacy of MAPK inhibitors in children with neurodegenerative Langerhans cell histiocytosis: Results from the European Consortium for HistiocytosisFrancesco Pegoraro, Francois Chalard, Dmitry Evseev, et al.
Blood|August 18, 2023
BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosisAldo A Acosta-Medina, Paul G Kemps, Timo C E Zondag, et al.
Blood Advances|February 12, 2026
Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patientsJean Donadieu, Dmitry Evseev, Francesco Pegoraro, et al.
Blood|November 2, 2021
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibitionPaul G Kemps, Jennifer Picarsic, Benjamin H Durham, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Blood Neoplasia|June 2, 2025
Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in BelgiumPaul G Kemps, F J Sherida H Woei-A-Jin, Patrick Schöffski, et al.
Frontiers in Immunology|January 31, 2020
Apparent Lack of <i>BRAF</i><sup></sup> Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8<sup>+</sup> T Cells in Langerhans Cell HistiocytosisPaul G Kemps, Timo C Zondag, Eline C Steenwijk, et al.
Blood|September 24, 2024
Recurrent CLTC::SYK fusions and CSF1R mutations in juvenile xanthogranuloma of soft tissuePaul G Kemps, Hans J Baelde, Ruben H P Vorderman, et al.
Blood Advances|September 9, 2022
Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort studyPaul G Kemps, Timo C E Zondag, Helga B Arnardóttir, et al.
Hemasphere|June 9, 2026
Efficacy of MAPK inhibitors in children with neurodegenerative Langerhans cell histiocytosis: Results from the European Consortium for HistiocytosisFrancesco Pegoraro, Francois Chalard, Dmitry Evseev, et al.
Blood|August 18, 2023
BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosisAldo A Acosta-Medina, Paul G Kemps, Timo C E Zondag, et al.
Blood Advances|February 12, 2026
Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patientsJean Donadieu, Dmitry Evseev, Francesco Pegoraro, et al.
Blood|November 2, 2021
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibitionPaul G Kemps, Jennifer Picarsic, Benjamin H Durham, et al.
Pageof 7